Supervised automated microscopy increases sensitivity and efficiency of detection of sentinel node micrometases in patients with breast cancer

Journal of Clinical Pathology

Volumn 57, Issue 9, 2004, Pages 960-964

  Mesker, W E ^a   Torrenga, H ^b   Sloos, W C R ^a   Vrolijk, H ^a   Tollenaar, R A E M ^a   De Bruin, P C ^c   Van Diest, P J ^b   Tanke, H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

ARTICLE; AUTOANALYSIS; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROSCOPY; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

AUTOMATION; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MICROSCOPY; PATHOLOGY, CLINICAL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 4544381400     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.017368     Document Type: Article

References (25)

1. Tjon-Heijnen VC, Bult P, de Widt-Evert LM, et al. Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel node procedure. Breast Cancer Res Treat 2001;70:81-8.
2. Fraile M, Rull M, Julian FJ, et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 2000;11:701-5.
3. Sandrucci S, Casalegno PS, Percivale P, et al. Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedures. Tumori 1999;85:425-34.
4. Widt-Levert LM de, Tjan-Heijnen VCG, Bult P, et al. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in sentinel lymph node. Eur J Surg Oncol 2003;29:216-20.
5. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:966-78.
6. Torrenga H, Rahusen FD, Meijer S, et al. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2001;54:550-2.
7. Cserni G. Complete step sectioning of axillary sentinel lymph nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 2002;55:926-31.
8. Rahusen FD, Van Diest PJ, Meijer S. Re: Chu, et al. "Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?". Ann Surg 2000;231:615-16.
9. Rahusen FD, Torrenga H, van Diest PJ, et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 2001;136:1059-63.
10. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet 1999;345:896-900.
11. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenedomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553-9.
12. Kelley WS, Komorowski R̀A, Dayer AM. Axillary sentinel lymph node examination in breast carcinoma. Arch Palhol Lab Med 1999;123:533-5.
13. Altinyollar H, Kapucuoglu N, Berberoglu U. Lymphatic mapping and sentinel lympnadenectomy in early stage breast carcinoma. J Exp Cancer Res 2000;19:141-4.
14. Liu LH, Siziopikou KP, Gabram S, et al. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma. Arch Pathol Lab Med 2000;124:1670-3.
15. Dowlatshahi K, Fan M, Anderson JM, et al. Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol 2001 ;8:675-81.
16. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual, 6th ed. New York: Springer, 2002.
17. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells. Clarification of the 6th edition of the American Joint Committee on Cancer staging manual. Cancer 2003;98:2740-1.
18. Weaver DL. Sentinel lymph nodes and breast carcinoma. Which micrometastases are clinically significant? Am J Surg Oncol 2003;27:842-5.
19. Leers MPG, Schoeffelen RHMG, Hoop JGM, et al. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer. J Clin Pathol 2002;55:359-66.
20. Weaver DL, Krag DN, Ashikaga T, et al. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast cancer; a multicenter study. Cancer 2000;88:1099-107.
21. Mesker WE, Doekhie FS, Vrolijk H, et al. Automated analysis of multiple sections for the detection of occult cells in lymph nodes. Clin Cancer Res 2003;9:4826-34.
22. Weaver DL, Krag DN, Manna EA, et al. Comparison of occult micrometastasis detection in breast cancer sentinel lymph nodes using manual cytokeratin immunohistochemistry and image analysis. Mod Pathol 2002;15:55A-6A.
23. Van Diest PJ. Histopathologic workup of sentinel lymph nodes: how much is enough [editorial]? J Clin Pathol 1999;52:871-3.
24. ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. Virchows Arch 2001;439:601-3.
25. Cserni G, Amendoeira I, Apostolikas N, et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003;39:1654-67.